Erowid Monthly
We're jokingly calling 2018 "Erowid's Year of Experience Report Ketchup". The upcoming issue of Erowid Extracts (#30) is dedicated to discussion and analysis of the Experience Vaults.

After over twenty years of collecting experience reports, we've been tidying data, upgrading systems to better handle the amount of information we now have, and making the types of changes that will enable new features and improvements for readers in the near future.

Launched with a couple hundred reports in June 2000, and approaching 32,000 published reports today, the Experience Vaults have exceeded the project's original scope and just keep growing.
In History...30 Years Ago
1988: DEA administrative law Judge Francis Young rules, after thorough hearings, that cannabis has clearly established medical use and should be reclassified as a prescription drug. His recommendation is ignored.
Cultural and Political Perspectives on Psychedelic Science
(Aug 18-19) CIIS, San Francisco, California

Speakers will offer a meta-reflexive approach to central aspects of the so-called "psychedelic renaissance".
Latest Additions
This issue announced the opening of five regional labs of the BNDD, including one in San Francisco with Robert Sager as chief chemist. Sager later became a good friend of Dr. Shulgin. Also, results of an analysis of a "mescaline tablet" that contained LSD and caffeine.
Analysis of LSD tablets--barrels, "Peace Tablets", and two sizes of orange "Sunshine"--with the first two containing 90-115 ug and the latter 255-256 ug of LSD. Also, an error identified by Dr. Shulgin about the structure of Ibogaine published in a 1968 issue, 35 drugs analyzed by BNDD, and more.
The eleventh in the series of translations of Erowid's guide to relating responsibly to psychoactive plants, drugs, and technologies.
Ecstasy Data
EcstasyData is an Erowid project that conducts laboratory testing of ecstasy tablets, research chemicals, and other drugs. We publish our results online along with analyses from other drug checking programs.
Crew Notes
The experience report crew is on track to reach an all-time high in report publishing in 2018. In archiving news, scanning of Shulgin materials is ongoing, volunteers are transcribing the next set of Shulgin Pharmacology Notebook pages, and we're working on writing abstracts for all items in the Stolaroff Collection.
Erowid is often mentioned in articles and books. Mentions may include positive or critical reviews, as well as citations of Erowid content.
  • "How to Change Your Mind: What the New Science of Psychedelics..."
    Penguin Press (May 2018)
    In Michael Pollan's Acknowledgements: "For crucial research assistance along the way [...] I'm deeply grateful to Earth and Fire, the proprietors of Erowid, which is the single most important resource on psychedelics there is." Awww...
  • "Guide to the management of gabapentinoid misuse"
    Prescriber (Apr 2018)
    "There is now a rich source of anecdotal reports that support significant misuse of gabapentinoids both in the UK and internationally, such as the user reports on the Erowid website."
More New Content
  1. MDMA: Anorexigenic Preparation and Method of Curbing the Appetite
    A patent filed in 1959 on the use of MDMA as an appetite suppressant. This is from Alexander Shulgin's file folders and is part of our Shulgin Archiving project. Thanks to K Trout for his ongoing work on this!
From the Vaults
A few years ago, using a redacted version of their original database and software, we made a complete copy of The Hive forums. Operational from 1997-2004, The Hive was infamous for its explicit discussions of chemistry, synthesis, and pharmacology of psychoactive chemicals. We hear from readers that they forget how extensive the twisty mazes inside Erowid are, and we want to remind people of some of the vast and deep vaults you might not normally run across.
Experience Reports
(see 2,047 new)
Donate Or Become A Member
If you find Erowid a useful resource and are interested in supporting its future development, please consider donating or becoming a member. Donations to Erowid Center are tax-deductible in the United States.
List Subscription Information
  • To UNSUBSCRIBE - send an empty email to:
  • To SUBSCRIBE - send an empty email to: